Glioma and Extracellular Matrix

Christian Mawrin,Constanze Seidenbecher

DOI: https://doi.org/10.1007/978-3-7091-1431-5_10

2014-01-01

Abstract:Invasion of glioma cells into brain tissue involves a multitude of molecular interactions of invading cells with host cells and with the surrounding extracellular matrix (ECM). The brain ECM is a complex structure composed of proteoglycans and glycoproteins of glial and neuronal origin, which is largely based on hyaluronic acid (HA) as central organizing glycosaminoglycan. It is particularly rich in different carbohydrate epitopes and undergoes a developmental shift around synaptogenesis and terminal maturation. Glioma cells do not only bind to ECM components via specific receptors which are highly expressed on their surfaces but they actively shape the ECM by secreting matrix constituents and ECM-modulating enzymes like proteases, glycosidases, or sulfatases, thus creating a permissive environment. Proteomic approaches have shown that the individual secretomes of different glioma cells can vary largely in their composition. This mutual glioma–host–ECM interaction, which also involves the microvasculature of the brain, contributes to the devastating nature of glioma tumors, because it enables the malignant cells to pave their way into the parenchyma. The complex nature of normal as well as glioma-derived ECM makes it challenging to identify entry points for a successful therapeutic treatment. First attempts targeting ECM receptors on glioma cells or technological approaches to change the biomechanical properties of brain ECM are promising but need more time.